PixelBiosciences GmbH was founded in Heidelberg, Germany, with its headquarters in Suzhou, China. We provide advanced technologies, products, and tools for researchers and developers of novel drug models. Our mission supports foundational research, cell and gene therapy, and RNA-based drug development. The nMECA platform offers a multifunctional, high-throughput, and cost-effective product portfolio to meet diverse synthesis needs. Our custom sgRNA products are widely adopted by leading gene editing companies and research institutions globally. Future products will encompass gene editing drug development, spatial biology, proteomics, and more.

PixelBiosciences GmbH houses advanced R&D laboratories, GMP facilities, and fully automated digital production lines in Suzhou, enabling comprehensive R&D and production capabilities. We are committed to providing the best solutions through innovation and excellent business practices, establishing long-term partnerships, and driving breakthroughs and success in biotechnology.

Serving a global clientele, including biopharmaceutical companies, diagnostic device companies, and research institutions, PixelBiosciences GmbH is dedicated to delivering high-quality products and services. Together, we aim to advance scientific progress and improve the quality of life for humanity and the planet.